Evidence map›Paper›PMID 36721851›Full record

ArticleMedComm2023

Cryo-EM structure of orphan G protein-coupled receptor GPR21.

Thian-Sze Wong, Wei Gao, Geng Chen, Chen Qiu, Guodong He, Fang Ye, Zhangsong Wu, Zicheng Zeng, Yang Du

Open access · goldAbstract read
In one paragraph

Article in MedComm, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Lipid Activation of a Thalamic GPCR Extends Working Memory Time-scales.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Molecular basis for ligand recognition and receptor activation of the prostaglandin D2 receptor DP1.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Thian-Sze WongKobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug, Discovery and Development, School of Medicine the Chinese University of Hong Kong Shenzhen Guangdong China.
Wei GaoKobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug, Discovery and Development, School of Medicine the Chinese University of Hong Kong Shenzhen Guangdong China.
Geng ChenKobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug, Discovery and Development, School of Medicine the Chinese University of Hong Kong Shenzhen Guangdong China.
Chen QiuKobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug, Discovery and Development, School of Medicine the Chinese University of Hong Kong Shenzhen Guangdong China.
Guodong HeSchool of Medicine Tsinghua University Beijing China.
Fang YeKobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug, Discovery and Development, School of Medicine the Chinese University of Hong Kong Shenzhen Guangdong China.
Zhangsong WuKobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug, Discovery and Development, School of Medicine the Chinese University of Hong Kong Shenzhen Guangdong China.
Zicheng ZengKobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug, Discovery and Development, School of Medicine the Chinese University of Hong Kong Shenzhen Guangdong China.
Yang DuKobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug, Discovery and Development, School of Medicine the Chinese University of Hong Kong Shenzhen Guangdong China.
Chinese University of Hong Kong, Shenzhen · CNTsinghua University · CNUnited States Government Accountability Office · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GPR21 belongs to class A orphan G protein-coupled receptor (GPCR). The endogenous ligands for human GPR21 remain unidentified. GPR21 expression is associated with developing type 2 diabetes (T2DM), a multifactorial metabolic disease caused by pancreatic β-cell dysfunction, decreasing insulin production, insulin resistance, and obesity. Animal studies suggested that GPR21 is a potential therapeutic target for T2DM treatment. The underlying mechanisms leading to GPR21 self-activation remain unknown. In our co-expression analysis, we noted that GPR21 could also form a stable complex with an unreported Gα protein subtype, Gαs. To gain further insights into the structural mechanisms of GPR21 activation, we employed cryo-electron microscopy (cryo-EM) and single-particle analysis to resolve the high-resolution structure of GPR21-Gαs complexes. The clear electron density map of the GPR21-Gαs provided direct evidence that GPR21 could couple to Gαs protein at physiological conditions. Thus, GPR21 might mediate previously unexplored pathways in normal or pathological conditions, which warrants further investigation. Structure-guided mutagenesis and biochemical analysis revealed that extracellular loop 2 (ECL2) of GPR21 is essential for the receptor transducing intracellular signal via cAMP. Together, the new structure data reveal a novel signaling cascade of human GPR21 mediated by ECL2 and provide fundamental information for future structure-based drug development.

Indexed as

cryo‐EMECL2GPCRGPR21orphan receptor

Identifiers

PMID36721851
PMCPMC9877262
OpenAlexW4318046636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.